Last reviewed · How we verify
TLN-254
At a glance
| Generic name | TLN-254 |
|---|---|
| Sponsor | Treeline Biosciences, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas (PHASE1)
- A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |